QCDR QPP Guide for Psychiatrists

In contrast to other behavioral health professionals, psychiatrists assist a patient panel with a greater psychopathology (schizophrenia, bipolar disorder, severe depression & anxiety) or those who prefer not to engage in therapy.  In accordance with regulations, psychiatrists can prescribe medication to treat the associated psychopathologies. 

There are several QPP measures that provide metrics for the various facets of psychiatric medications and associated psychopathologies.

2016 QPP Measures for Psychologists

See detailed descriptions for 2016 QPP measures here.

• Major depressive disorder: antidepressant medication during acute phase for patients with MDD (#9)

• Major depressive disorder: diagnostic evaluation (#106)

• Major depressive disorder: suicide risk assessment (#107)

• Preventive care and screening: Body mass index screening and follow-up (#128)

• Documentation and verification of current medications in the medical record (#130)

• Pain assessment prior to initiation of patient therapy and follow-up (#131)

• Screening for clinical depression and follow-up plan (#134)

• Preventive care and screening: Unhealthy alcohol use—screening (#173)

• Elder maltreatment screen and follow-up plan (new measure effective in 2009)

• Preventive care and screening: Tobacco use assessment and tobacco cessation intervention (#226)

• Substance use disorders – counseling (#247)

• Substance use disorders – Screening for depression (#248)

• Adult Major Depressive Disorder (MDD): Coordination of Care of Patients with Specific Comorbid Conditions (#325)

Note: there are major changes in 2016 for QPP measures.  Please visit this site for updates.

CUHSM.org is a QCDR registered with CMS that provides QPP support to mental and behavioral health professionals.   We streamline the QPP reporting process by providing alternative methods that integrate with the CMS billing workflow of providers, especially for those providers who do not use an EHR: